Pontifax (Israel) IV, L.P. — insider trades

Stock trades Pontifax (Israel) IV, L.P. reported on SEC Form 4 at KROS Keros Therapeutics, Inc..

• Oct 15, 2025: sold 4,787,331 shares of KROS Keros Therapeutics, Inc. ($85.0M)